Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-20T11:41:41.823Z Has data issue: false hasContentIssue false
  • English
  • Français

Efficacy and safety of a novel long-acting risperidone formulation

Published online by Cambridge University Press:  16 April 2020

J. Kane ,
M. Eerdekens ,
S. Keith ,
M. Claghorn-Lesem ,
K. Karcher  and
J.-P. Lindenmayer
J. Kane
Affiliation:
Hillside Hospital
M. Eerdekens
Affiliation:
Janssen Research Foundation
S. Keith
Affiliation:
University of New Mexico-School of Medicine
M. Claghorn-Lesem
Affiliation:
Lesem Research Clinic
K. Karcher
Affiliation:
Janssen Research Foundation
J.-P. Lindenmayer
Affiliation:
Manhattan Psychiatric Center, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Tuesday, 7 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 193s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.